Citation

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2010 Jul 01; 54(3):285-9. PMID: 19890215; PMCID: PMC3119357.

Citation

Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Research and Human Retroviruses. 2010 May 01; 26(5):563-568. PMID: 20455758; PMCID: PMC2875950.

Citation

Analysis of HIV diversity using a high-resolution melting assay. AIDS Research and Human Retroviruses. 2010 Aug 26; 26(8):913-8. PMID: 20666583; PMCID: PMC2920076.

Citation

Clinical evaluation of a dried blood spot assay for atazanavir. Antimicrobial Agents and Chemotherapy. 2010 Oct 01; 54(10):4124-8. PMID: 20660680; PMCID: PMC2944558.

Citation

Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. Journal of Immunological Methods. 2010 Aug 01; 363(1):42-50. PMID: 20888337; PMCID: PMC3068047.

Citation

Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins. Journal of Biological Chemistry. 2010 Jun 11; 285(24):18319-25. PMID: 20378550; PMCID: PMC2881757.

Citation

Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS. 2010 Feb 20; 24(4):557-61. PMID: 20057308; PMCID: PMC3065236.

Citation

Gregory K. Robbins, M.D., M.P.H., John Spritzler, Sc.D., Ellen Chan, M.Sc., David M. Asmuth, M.D., Rajesh Gandhi, M.D., Benigno Rodriguez, M.D., Gail Skowron, M.D., Paul Skolnik, M.D., Robert Shafer, M.D., Richard B. Pollard, M.D. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group Protocol 384. Clinical Infectious Diseases. 2009 Feb 01; 48(3):350-61. PMID: 19123865; PMCID: PMC2676920.

Citation

Rajesh Gandhi, M.D., David O'Neill, M.D., Ronald J. Bosch, Ph.D., Ellen Chan, M.Sc., R. Pat Bucy, M.D., Ph.D., J. Shopis, Lynn Baglyos, M.S.N, Elizabeth Adams, M.D., Lawrence Fox, M.D., Ph.D., Lynette Purdue, Pharm.D., Ann Marshak, Teri Flynn, R.N., A.N.P., M.S.N, Reena Masih, M.A., Barbara Schock, M.S., Donna Mildvan, M.D., Sarah J. Schlesinger, M.D., Mary A Marovich, M.D., DTM&H, Nina Bhardwaj, M.D., Ph.D., Jeffrey M. Jacobson, M.D. A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 2009 Oct 09; 27(43):6088-94. PMID: 19450647; PMCID: PMC2820102.

Citation

Timothy J. Wilkin, M.D., M.P.H., Timothy J. Wilkin, M.D., M.P.H., John Ernest McKinnon, M.D., Greg DiRienzo, Ph.D., Katie Mollan, M.S., Courtney V. Fletcher, Pharm.D., David M. Margolis, M.D., Barbara Bastow, R.N., B.S.N., Gary D. Thal, M.D., William Chris Woodward, D.O., Catherine Godfrey, M.D., A. Wiegand, Frank Maldarelli, Sarah Palmer, Ph.D., John Coffin, M.D., John W. Mellors, M.D., Susan Swindells, M.B.B.S. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. Journal of Infectious Diseases. 2009 Mar 15; 199(6):866-71. PMCID: PMC2756462.